Zofingen, Mai 31, 2012 -- Effective immediately, Siegfried Holding AG (SIX: SFZN) has acquired Alliance Medical
Products, Inc. (AMP), Irvine, California. This acquisition gives Siegfried an entry into
the custom market for sterile filling services.
Complementing the company’s technology base with competency in sterile filling services is
a strategic goal for the Siegfried Group. By taking over 100% of the shares of privately-held
Alliance Medical Products (AMP), the Swiss pharmaceutical supplier makes a substantial
step toward additional profitable growth. The purchase price of $58 million is to be paid
immediately, with a contingent earn-out to be paid if defined profitability goals have been met
for the fiscal year ended December 31, 2013. The transaction is expected to be accretive
already in 2012.
Attractive company with solid track record
Founded in 2001, AMP is based in Irvine, California and provides sterile filling services for
medications – an attractive segment of the pharmaceutical custom market. The company
achieved revenues of $20 million in 2011 with approximately 100 employees.
AMP is operating profitably, has an attractive client base and a substantial project pipeline.
The company is expected to continue its growth and provide a strong contribution to the
equity value of the Siegfried Group. In order to ensure a seamless integration the
management of AMP will remain in place.
The acquisition provides various synergies for both companies, especially in the areas of
technology and marketing. Dr. Rudolf Hanko, Siegfried CEO, explains: “Siegfried is one of
the few companies with capabilities in both pharmaceutical and chemical manufacturing.
Our acquisition of AMP expands this exceptional offer into the sterile filling market, a
particularly attractive segment. Integrating AMP into the Siegfried Group is an asset for both
Juan Valdes, AMP CEO, adds: “Our association with Siegfried opens interesting growth and
expansion possibilities for AMP. The combination of sterile filling services with the production
of active pharmaceutical ingredients is unique in the custom manufacturing market.”
Siegfried will hold a conference call at 2.00 p.m (CET). The coordinates are as follows:
0800 002 145
+41 (0)22 580 59 81
+41 (0)44 580 33 40
Participants PIN: 93233313#
The presentation prior to the conference call will be uploaded to the website at 1.00 p.m. (CET)
For further information:
Peter Gehler, Head Corporate Center
Phone +41 (0)62 746 11 48
Mobile +41 (079) 416 41 16
Fax +41 (0)62 746 11 03
Siegfried Holding AG
Untere Brühlstrasse 4
Pone +41 (0)62 746 11 11
Fax +41 (0)62 746 11 03
The Siegfried Group is active worldwide in the field of Life Sciences with production facilities located in
Switzerland, Malta and the USA. At the end of 2011, Siegfried employed approximately 700 employees and
reported annual sales of CHF 328 million. Siegfried Holding AG is listed on the Swiss Exchange (SIX: SFZN).
Siegfried is active in both the primary and secondary production of drugs. The company develops and
manufactures active pharmaceutical ingredients for the research-based pharmaceutical industry as well as the
corresponding intermediate steps and controlled substances, and provides development and production services
for drugs in finished dosage forms.
About Alliance Medical Products
Alliance Medical Products is a full service FDA, MHRA and ISO13485 certified Contract Manufacturing
Organization (CMO), who provides pharmaceutical companies with a complete single source solution from early
stage through high volume commercial manufacturing.
With over 100 employees in its Irvine California location, Alliance Medical Products offers custom fill finish
services in sterile liquid, suspension, emulsion, ointments and specialty combo delivery devices, with a focus on
unique and difficult to manufacture products.